Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids

British Journal of Rheumatology

Volumn 37, Issue 4, 1998, Pages 405-410

  Li, E K ^a   Tam, L S ^a   Young, R P ^a   Ko, G T C ^a   Li, M ^a   Lau, E M C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bone mineral density; Calcium; Chinese; Corticosteroid; SLE

Indexed keywords

CALCIUM; CORTICOSTEROID; PREDNISONE;

ABSORPTIOMETRY; ADULT; ARTICLE; ASIA; BODY MASS; BONE DENSITY; BONE MINERAL; CAUCASIAN; CHINESE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ACTIVITY; FEMALE; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; X RAY ANALYSIS;

ADRENAL CORTEX HORMONES; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; CALCIUM; CALCIUM, DIETARY; CROSS-SECTIONAL STUDIES; FEMALE; HOMEOSTASIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PREMENOPAUSE; PREVALENCE;

EID: 0031875915     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dhillon VB, Davies MC, Hall ML et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry. Ann Rheum Dis 1990;49:624-6.
2. Kalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
3. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
4. Pons F, Peris P, Guanabens N et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-6.
5. Houssiau FA, Lefebvre C, Depresseux G, Lambert M, Devogelaer JP, Nagant De Deuxchaisnes C. Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996;35:244-7.
6. 44Ca). Br J Nutr 1994;72:883-97.
7. Leung SSF, Lee WTK, Cheng JCY, Fairweather-Tait S. The calcium absorption of Chinese children in relation to their intake. Hong Kong Med J 1995;1:58-62.
8. Sugimoto T, Tsumisumi M, Fujii Y et al. Comparison of bone mineral content among Japanese, Koreans and Taiwanese assessed by dual-photon absorptiometry. J Bone Miner Res 1992;7:153-9.
9. Hegsted DM. Calcium and osteoporosis. J Nutr 1986;116:2316-9.
10. Luz Villa M, Nelson L. Race, ethnicity and osteoporosis. In: Marcus R, Feldman P, Kelsy J, eds. Osteoporosis. Academic Press, USA, 1996.
11. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-5.
12. Steinbrocker O, Traeger CH, Batterman RE. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 1947;140:659-7.
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
14. Lau E, Donnan S, Barker DJ, Cooper C. Physical activity and calcium intake in fracture of proximal femur in Hong Kong. Br Med J 1988;297:1441-3.
15. Ho SC, Hsu SYC, Leung PC et al. A longitudinal study of the determinants of bone mass in Chinese women aged 21 to 40.1 Baseline association of anthropomorphic measurements with bone mineral density. Ann Epidemiol 1993;3:256-63.
16. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series, No. 843. Geneva: WHO, 1994.
17. Sel F, Dequeker J, Verwilghen J, Mbuyi-Muamba J-M. Viewpoint SLE and osteoporosis: dependence and/or independence on glucocorticoids. Lupus 1996;5:89-92.
18. Horslev-Petersen K et al. Influence of disease activity and drug treatment on bone mineral content (BMD) in patients with systemic lupus erythematosus. Rheumatol Eur 1995;24(suppl 3):11.
19. Petri M. Osteoporosis in SLE: prednisone affects lumbar spine more than other areas. Arthritis Rheum 1996;39(suppl.):S667.
20. Seeman E, Wahner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 1982;69:1302-9.
21. Sambrook PN, Birmingham J, Kempler S et al. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res 1990;5:1211-6.
22. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, OzeriChen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991;147:117-23.
23. Adachi J, Bensen W, Bianchi F et al. Vitamin D and calcium in the prevention of corticosteroid osteoporosis: A 3 year follow-up. J Rheumatol 1996;23:995-1000.
24. Ringe JD, Welzel D, Schmid K. Therapy of corticoidinduced osteoporosis with salmon calcitonin. In Christiansen C, Johanson JS, Riis BJ, eds. Osteoporosis. Copenhagen: Osteopress, 1987:1074-6.
25. Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1980;30:83-103.
26. Sambrook P, Birmingham J, Kelly P et al. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993;328: 1747-52.
27. Sambrook PN, Jones G. Corticosteroid osteoporosis. Br J Rheumatol 1995;34:8-12.
28. Matsuyama T, Ishii S, Tokita A et al. Vitamin D receptor genotypes and bone mineral density. Lancet 1995;345:1238-9.
29. Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-7.
30. Dawson-Hughes B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995;80:3657-61.
31. Young RP, Lau EMC, Birjandi Z, Critchley JAJH, Woo J. Interethnic differences in hip fracture rate and the Vitamin D receptor polymorphism. Lancet 1996;348:688-9.